TMJ Disorder, TMJ Disc Disorder
Conditions
Brief summary
This prospective, randomized control study aimed to compare the Clinical Outcome of Hegab splint, Arthrocentesis, and Arthroscopy in treatment of TMJ closed lock. The study sample was derived from the population of patients who presented for evaluation and treatment of TMJ disorders.
Detailed description
This prospective, randomized control study aimed to compare the Clinical Outcome of Hegab splint, Arthrocentesis, and Arthroscopy in treatment of TMJ closed lock. The study sample was derived from the population of patients who presented for evaluation and treatment of TMJ disorders. The patients were randomly assigned to one of the following three groups: Group I (Control): patients treated by Hegab splint. Group II: patients treated by arthrocentesis with injection of HA/PRP mix plus Hegab splint. Group III: arthroscopy with injection of HA/PRP mix plus Hegab splint. The primary outcome variable was the change in pain using a visual analog scale, and improvement of maximum voluntary mouth opening. The secondary outcome variable was the change in joint sound. The third category of variables (age and sex) was evaluated in relation to the outcomes.
Interventions
TMJ arthrocentesis and arthroscopy
Sponsors
Study design
Intervention model description
The patients were randomly assigned to one of the following three groups: Group I (Control): patients treated by Hegab splint. Group II: patients treated by arthrocentesis with injection of HA/PRP mix plus Hegab splint. Group III: arthroscopy with injection of HA/PRP mix plus Hegab splint. The primary outcome variable was the change in pain using a visual analog scale, and improvement of maximum voluntary mouth opening. The secondary outcome variable was the change in joint sound. The third category of variables (age and sex) was evaluated in relation to the outcomes
Eligibility
Inclusion criteria
* Patients with TMJ closed lock confirmed
Exclusion criteria
* rheumatoid arthritis psoriatic arthritis juvenile arthritis those receiving anticoagulant therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change in pain using a visual analog scale, | one year | The primary outcome variable was the change in pain using a visual analog scale (VAS), with 0 indicating the absence of pain and 10 indicating the worst pain possible |
| improvement of maximum voluntary mouth opening | one year | improvement of maximum voluntary (non-assisted) mouth opening (MVMO) in millimetres. |
Countries
Egypt